Whole Genome Sequencing as a First-Line Clinical Test: Almost Ready for Prime Time
- PMID: 34529612
- DOI: 10.1097/CCM.0000000000005077
Whole Genome Sequencing as a First-Line Clinical Test: Almost Ready for Prime Time
Conflict of interest statement
Dr. Dahmer has disclosed that she does not have any potential conflicts of interest.
Comment on
-
Application of Full-Spectrum Rapid Clinical Genome Sequencing Improves Diagnostic Rate and Clinical Outcomes in Critically Ill Infants in the China Neonatal Genomes Project.Crit Care Med. 2021 Oct 1;49(10):1674-1683. doi: 10.1097/CCM.0000000000005052. Crit Care Med. 2021. PMID: 33935161
References
-
- Willig LK, Petrikin JE, Smith LD, et al.: Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: A retrospective analysis of diagnostic and clinical findings. Lancet Respir Med. 2015; 3:377–387
-
- French CE, Delon I, Dolling H, et al.; NIHR BioResource—Rare Disease; Next Generation Children Project: Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children. Intensive Care Med. 2019; 45:627–636
-
- Sanford EF, Clark MM, Farnaes L, et al.; RCIGM Investigators: Rapid whole genome sequencing has clinical utility in children in the PICU. Pediatr Crit Care Med. 2019; 20:1007–1020
-
- Wu B, Kang W, Wang Y, et al.: Application of Full-Spectrum Rapid Clinical Genome Sequencing Improves Diagnostic Rate and Clinical Outcomes in Critically Ill Infants in the China Neonatal Genomes Project. Crit Care Med. 2021; 49:1684–1693
-
- Aziz N, Zhao Q, Bry L, et al.: College of American Pathologists’ laboratory standards for next-generation sequencing clinical tests. Arch Pathol Lab Med. 2015; 139:481–493
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
